Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation

2012 ◽  
Vol 94 (8) ◽  
pp. 879-883 ◽  
Author(s):  
Anna D. Petropoulou ◽  
Raphael Porcher ◽  
Regis Peffault de Latour ◽  
Alienor Xhaard ◽  
Daniel Weisdorf ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Infection Rate ◽  
Epstein Barr Virus ◽  
Virus Reactivation ◽  
Hematopoietic Stem ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation

2017 ◽  
Vol 59 (9) ◽  
pp. 973-978 ◽  
Author(s):  
Shogo Kobayashi ◽  
Hideki Sano ◽  
Kazuhiro Mochizuki ◽  
Yoshihiro Ohara ◽  
Nobuhisa Takahashi ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Epstein Barr Virus ◽  
Virus Reactivation ◽  
Hematopoietic Stem ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation
Sign in / Sign up

Export Citation Format

Share Document